ArticleClinical rheumatology2019
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis.
Claudia Fabiani et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this papercites it